4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-004402
Chief Scientific Officer gave up 21,283 shares (to pay taxes)
- Chief Scientific Officer acquired 73,425 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2024-03-01 | Option exercise | +50,000 | 184,641 | D: show line 1 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2024-03-01 | Shares withheld for taxes | −14,569 | $1.24 | $18,066 | 170,072 | D: show line 2 in the form |
| Monahan Joseph Chief Scientific Officer | 2024-03-01 | Option exercise | +10,925 | 180,997 | D: show line 3 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2024-03-01 | Shares withheld for taxes | −3,183 | $1.24 | $3,947 | 177,814 | D: show line 4 in the form |
| Monahan Joseph Chief Scientific Officer | 2024-03-02 | Option exercise | +12,500 | 190,314 | D: show line 5 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2024-03-02 | Shares withheld for taxes | −3,531 | $1.24 | $4,378 | 186,783 | D: show line 6 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2024-03-01 | Option exercise · Restricted Stock Units | −50,000 | 50,000 | D: show line 7 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2024-03-01 | Option exercise · Restricted Stock Units | −10,925 | 21,850 | D: show line 8 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2024-03-02 | Option exercise · Restricted Stock Units | −12,500 | 0 | D: show line 9 in the form |
Loading xslF345X05/doc4.xml…